Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/1998
11/24/1998US5840743 Modified benzimidazole nucleosides as antiviral agents
11/24/1998US5840742 Pharmaceutical composition for inhibiting the growth of cancers
11/24/1998US5840707 A protein or peptide formulation comprising a polynucleotide component, a negatively charge lipid component and a divalent cation component
11/24/1998US5840700 Methods of producing transfer factor
11/24/1998US5840684 Bactericides for vancomycin resistant bacteria
11/24/1998US5840563 Method for growing swine infertility and respiratory syndrome virus
11/24/1998US5840544 DNA encoding rantes homolog from prostate
11/24/1998US5840538 Lgt
11/24/1998US5840526 Two heavy polypeptide chains with variable and constant regions including complete antigen binding sites; constant region lacks ch1 domain; increased ease of preparation by genetic engineering; medical diagnosis
11/24/1998US5840480 Retrovirus from the HIV group and its use
11/24/1998US5840315 Treating or preventing bovine mastitis
11/24/1998US5840302 Treatment of bacterially-induced inflammatory diseases
11/24/1998US5840298 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
11/24/1998US5840297 Vaccine comprising anti-idiotypic antibody to chlamydia GLXA and process
11/22/1998CA2231017A1 A member of the frzb family, frazzled
11/19/1998WO1998051692A1 Acyclovir diester derivatives
11/19/1998WO1998051665A2 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998WO1998051339A1 Multivalent vaccine composition with mixed carrier
11/19/1998WO1998051335A1 Methods of modulating immune coagulation
11/19/1998WO1998051334A1 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
11/19/1998WO1998051328A1 Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets
11/19/1998WO1998051306A1 Medicinal compositions against helicobacter pylori
11/19/1998WO1998051304A1 Benzimidazole-2-carbamates for the treatment of viral infections and cancer
11/19/1998WO1998051303A1 Hiv and cancer treatment
11/19/1998WO1998051295A1 Hiv-1 protease inhibitors, process for producing the same, and medicinal compositions
11/19/1998WO1998040483A3 28 human secreted proteins
11/19/1998WO1998040058A3 Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides
11/19/1998WO1998037089A3 Matrix derived anti-hiv peptides and transdominant proteins
11/19/1998WO1998036741A3 Use of 2-desoxyglucose for suppressing viral transcription
11/19/1998WO1998035694A3 A pharmaceutical composition for treating hepatitis b virus (hbv) infection
11/19/1998WO1998035014A3 Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom
11/19/1998WO1998034640A3 Synthetic hiv gag genes
11/19/1998WO1998033896A3 Microorganisms with increased production of clavulanic acid
11/19/1998WO1998033490A3 Use of percaboxylic acids in the control of hairy wart disease
11/19/1998CA2289969A1 Acyclovir diester derivatives
11/19/1998CA2289550A1 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
11/19/1998CA2287923A1 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998CA2268848A1 Hiv and cancer treatment
11/19/1998CA2259425A1 Hiv-1 protease inhibitors, process for producing the same, and medicinal compositions
11/19/1998CA2221866A1 A novel member of the il-1 family, il-1 delta
11/18/1998EP0878545A2 OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines
11/18/1998EP0878542A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
11/18/1998EP0878479A2 G-protein coupled receptor (HOFNH30)
11/18/1998EP0878192A2 Method for treating protozoal infections
11/18/1998EP0877816A1 Expression of group b neisseria meningitidis outer membrane (mb3) protein from yeast and vaccines
11/18/1998EP0877755A1 Two-component signal transduction response regulator polypeptides from staphylococcus aureus
11/18/1998EP0877739A1 Azole compounds endowed with antimycotic activity for human and veterinary use
11/18/1998EP0877624A1 Streptococcal c5apeptidase vaccine
11/18/1998EP0877613A2 Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
11/18/1998EP0877605A2 Solid instant-release forms of administration and process for producing the same
11/18/1998EP0757669B1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them
11/18/1998EP0724581B1 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
11/18/1998EP0706514B1 Compounds and methods for inhibition of hiv and related viruses
11/18/1998EP0690990B1 Parvovirus receptors and methods of use
11/18/1998EP0581836B1 Hybrid transposon with a pt-operon, plasmids and bacterial strains therefor
11/18/1998CN1199337A Method of inhibiting plasminogen activator inhibitor 1
11/18/1998CN1198940A Medicine for pulmonary tuberculosis and its preparation method
11/18/1998CN1040759C Carbo-acyclic nucleoside derivs. as antiviral and antineoplastic agents
11/18/1998CN1040718C Method for treatment of disease of shrimp
11/17/1998US5837734 Method for the treatment of coccidioidomycosis in warm-blooded animals
11/17/1998US5837710 Enzyme inhibitors for treatment of aids
11/17/1998US5837541 Capable of protecting against bacterial infections
11/17/1998US5837532 Herpes simplex cirus type 1 mutant
11/17/1998US5837510 Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders
11/17/1998US5837499 Genetic engineering with polypeptides and dna molecules
11/17/1998US5837472 Nucleotide sequences coding for a protein with urease activity
11/17/1998US5837441 Immunoassay for detecting human antibodies to the hards virus, the etiologic aganet of hantavirus-associated respiratory distress syndrome
11/17/1998US5837257 Use of plant extracts for treatment of HIV, HCV and HBV infections
11/17/1998US5837251 Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
11/17/1998US5837244 Treating a cell proliferative disorder
11/13/1998CA2230971A1 G-protein coupled receptor (hofnh30)
11/12/1998WO1998050556A2 Intracellular production of hepatitis c e1 and e2 truncated polypeptides
11/12/1998WO1998050555A2 Enterococcus faecalis polynucleotides and polypeptides
11/12/1998WO1998050554A2 Enterococcus faecalis polynucleotides and polypeptides
11/12/1998WO1998050426A1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays
11/12/1998WO1998050402A1 Dna molecule conferring on mycobacterium tuberculosis resistance against antimicrobial reactive oxygen and nitrogen intermediates
11/12/1998WO1998050080A1 Methods of screening compounds useful for prevention of infection or pathogenicity
11/12/1998WO1998050066A1 Potentiation of the immune response through delivery of compounds binding a cytoplasmic dipeptidase
11/12/1998WO1998050046A1 Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv
11/12/1998WO1998050045A1 Improvements in or relating to long-acting antimicrobials
11/12/1998WO1998050035A1 Pharmaceutical compositions of tizoxanide and nitazoxanide
11/12/1998WO1998050022A1 Diphenylacetic acid derivatives and their use as antiviral agents
11/12/1998WO1998027966A3 Encapsulated cells producing antibodies
11/12/1998WO1997039128A3 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
11/12/1998CA2703181A1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays
11/12/1998CA2289125A1 Potentiation of the immune response through delivery of compounds binding a cytoplasmic dipeptidase
11/12/1998CA2289124A1 Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv
11/12/1998CA2289116A1 Enterococcus faecalis polynucleotides and polypeptides
11/12/1998CA2288944A1 Enterococcus faecalis polynucleotides and polypeptides
11/12/1998CA2288374A1 Intracellular production of hepatitis c e1 and e2 truncated polypeptides
11/12/1998CA2287774A1 Methods of screening compounds useful for prevention of infection or pathogenicity
11/11/1998EP0877085A1 OspA protein of borrelia burgdorferi subgroups, encoding genes and vaccines
11/11/1998EP0877083A1 A novel human G-protein coupled receptor (HCEPT09)
11/11/1998EP0877032A1 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers
11/11/1998EP0876613A1 Treatment and diagnosis of infections due to helicobacter pylori
11/11/1998EP0876498A1 Mixture of recombinant vaccinia vectors as polygeur vaccines for hiv
11/11/1998EP0876482A1 Il-13 receptor polypeptide
11/11/1998EP0876476A1 Heterophil-adapted poultry vaccine
11/11/1998EP0876398A1 Induction of immune response against desired determinants
11/11/1998EP0876395A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
1 ... 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 ... 1798